AK

Aleti Kanakaiah

Director Director DIN 07727354
DIN 07727354 First appointment Mar 2017 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2017
Shareholding value Locked Premium profile

About Aleti Kanakaiah

Data last updated:

Aleti Kanakaiah has 9 years in corporate governance. Formerly with 1 company, such as Chromgene Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 07727354
Primary Designation Director
First Appointment 20 Mar 2017
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Chromgene Biotech Private Limited U33300AP2017PTC105458
Director20 Mar 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chromgene Biotech Private Limited
Premium access

Shareholding and investment profile for Aleti Kanakaiah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aleti Kanakaiah

Aleti Kanakaiah has 9 years in corporate governance. Formerly with 1 company, such as Chromgene Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Aleti Kanakaiah is associated with 0 companies as a director.

Aleti Kanakaiah has expertise in Technology.

Aleti Kanakaiah has 9 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available